Clinical trials
Completed Observational Weight Loss trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
104 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 6 |
| 2011 | 1 |
| 2012 | 7 |
| 2013 | 4 |
| 2014 | 9 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 104 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| DiaSorin Inc. | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| Geisinger Clinic | 2 |
| Imperial College London | 2 |
| Karolinska Institutet | 2 |
| Pennington Biomedical Research Center | 2 |
| University Hospital, Montpellier | 2 |
| University of British Columbia | 2 |
| University of Colorado, Denver | 2 |
| University of Texas Southwestern Medical Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weight Loss | 104 |
| Obesity | 53 |
| Obesity, Morbid | 13 |
| Overweight | 12 |
| Diabetes Mellitus | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Inflammation | 6 |
| Insulin Resistance | 6 |
| Neoplasms | 5 |
| Abdominal Pain | 3 |
Trials
Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.
4 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.